1. The more invasive segment 4b/5 resection did not improve overall or disease-free survival compared to wedge resection in gallbladder...
1. Simvastatin (Zocor) in combination with paclitaxel (Taxol) is well tolerated and associated with significantly reduced disease progression compared to...
1. In patients with resected stage III mismatch repair-deficient colon cancer, adjuvant atezolizumab plus standard chemotherapy improved disease-free survival compared...
1. Statin use did not increase the risk of developing breast cancer among postmenopausal women. Evidence Rating Level: 2 (Good)...
Roche and NVIDIA deploy the pharmaceutical industry's largest AI factory A major leap in computational drug development has emerged with...
1. The combination of talazoparib and enzalutamide demonstrated a statistically significant improvement in radiographic progression-free survival for metastatic hormone-sensitive prostate...
Pfizer’s Talzenna combo significantly delays progression in frontline prostate cancer Topline results from the Phase 3 TALAPRO-3 study indicate that...
1. The mesenteric approach to pancreatoduodenectomy did not improve overall survival compared to the conventional Kocher-first approach in patients with...
1. Sitagliptin demonstrated the most prominent malignancy-related safety signal among the dipeptidyl peptidase-4 inhibitors studied. Evidence Rating Level: 2 (Good) ...
1. In this randomized controlled trial, administering pegfilgrastim 72 hours after chemotherapy reduced bone pain compared with 24- or 48-hour...
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.
